Journal of Medical Economics · 2022 · 12 citations · 24 references
After matching, VNS was associated with significantly lower all-cause and epilepsy-related costs for the two-year period following implantation. All-cause and epilepsy-related costs remained statistically significantly lower for VNS even after costs of implantation were excluded.
24
Hude Quan, Bing Li, Chantal Marie Couris et al. · American Journal of Epidemiology · 2011 · 5.6K citations · Full text
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy
Dileep Nair, Kenneth D. Laxer, Peter Weber et al. · Neurology · 2020 · 461 citations · Full text